381 related articles for article (PubMed ID: 18327996)
21. [Considerable remaining risk in unchecked LDL lowering. Is the HDL increase the way out?].
MMW Fortschr Med; 2006 Jun; 148(24):6, 8. PubMed ID: 16856232
[No Abstract] [Full Text] [Related]
22. [Dyslipidemia and global cardiovascular risk: treatment guidelines].
Vigna GB; Fellin R
Ital Heart J; 2003 Dec; 4 Suppl 7():4S-12S. PubMed ID: 14983742
[TBL] [Abstract][Full Text] [Related]
23. [Dyslipidemia in the elderly].
Lasses y Ojeda LA; Gutiérrez JL; Salazar E
Arch Cardiol Mex; 2004; 74(4):315-26. PubMed ID: 15709510
[TBL] [Abstract][Full Text] [Related]
24. [Hyperlipidemia and coronary heart disease].
Brugger P
Wien Med Wochenschr; 1990 Jul; 140(14):382, 384-6. PubMed ID: 2219944
[TBL] [Abstract][Full Text] [Related]
25. Clinical practice guidelines for the management of dyslipidemia.
Nichols N
Can J Cardiovasc Nurs; 2004; 14(2):7-10. PubMed ID: 15230023
[TBL] [Abstract][Full Text] [Related]
26. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
Chi YW; Jaff MR
Catheter Cardiovasc Interv; 2008 Mar; 71(4):475-89. PubMed ID: 18307227
[TBL] [Abstract][Full Text] [Related]
27. Statin and ezetimibe combination therapy in cardiovascular disease.
Dembowski E; Davidson MH
Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):183-8. PubMed ID: 19262375
[TBL] [Abstract][Full Text] [Related]
28. A pilot randomized trial comparing an intensive versus a standard intervention in stable HIV-infected patients with moderate-high cardiovascular risk.
Masiá M; Bernal E; Padilla S; García N; Escribano JC; Martínez E; Gutiérrez F
J Antimicrob Chemother; 2009 Sep; 64(3):589-98. PubMed ID: 19625372
[TBL] [Abstract][Full Text] [Related]
29. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA
Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582
[TBL] [Abstract][Full Text] [Related]
30. A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.
Davidson M
Am J Cardiol; 2008 Dec; 102(12A):19L-27L. PubMed ID: 19084086
[TBL] [Abstract][Full Text] [Related]
31. Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a).
Ozdöl S; Sahin S; Tokgözoğlu L
Int J Dermatol; 2008 Aug; 47(8):785-9. PubMed ID: 18717856
[TBL] [Abstract][Full Text] [Related]
32. Unmet need in the hyperlipidaemia population with high risk of cardiovascular disease: a targeted literature review of observational studies.
Mitchell S; Roso S; Samuel M; Pladevall-Vila M
BMC Cardiovasc Disord; 2016 Apr; 16():74. PubMed ID: 27114245
[TBL] [Abstract][Full Text] [Related]
33. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
Bays HE; Tighe AP; Sadovsky R; Davidson MH
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):391-409. PubMed ID: 18327998
[TBL] [Abstract][Full Text] [Related]
34. Aortic sclerosis, aortic stenosis and lipid-lowering therapy.
Rosenhek R; Baumgartner H
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):385-90. PubMed ID: 18327997
[TBL] [Abstract][Full Text] [Related]
35. Overview of prevention and treatment of atherosclerosis with lipid-altering therapy for pharmacy directors.
Davidson MH
Am J Manag Care; 2007 Dec; 13 Suppl 10():S260-9. PubMed ID: 18095776
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.
Teoh H; Mendelsohn AA; Goodman SG; Jaffer S; Chen RY; Tjia S; Theriault L; Langer A; Leiter LA;
Am J Cardiol; 2009 Sep; 104(6):798-804. PubMed ID: 19733714
[TBL] [Abstract][Full Text] [Related]
37. Is there a problem with ezetimibe or just ENHANCEd hype?
Whayne TF
Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
[No Abstract] [Full Text] [Related]
38. Hyperlipidemia in children.
McCrindle BW
Thromb Res; 2006; 118(1):49-58. PubMed ID: 16709475
[TBL] [Abstract][Full Text] [Related]
39. Dyslipidemia therapy update: the importance of full lipid profile assessment.
Menown IB; Murtagh G; Maher V; Cooney MT; Graham IM; Tomkin G
Adv Ther; 2009 Jul; 26(7):711-8. PubMed ID: 19649582
[TBL] [Abstract][Full Text] [Related]
40. Familial hypercholesterolemia: current treatment and advances in management.
Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA
Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
